Please login to the form below

Not currently logged in
Email:
Password:

Jayson Dallas to lead Roche in the UK

He takes over from John Melville who has retired

Roche Jayson DallasRoche has appointed Jayson Dallas to take over from John Melville who has retired after 12 years as the general manager of Roche Products.

Dallas officially took over leadership of the company on January 2, 2013, and is based at its Welwyn Garden City site in Hertfordshire.

Dallas said: “The next few years will provide many opportunities for Roche UK and I am excited at the prospect of how we can ensure that more patients can benefit from our innovative medicines as the access to medicines agenda still remains of critical importance.

“I look forward to reconnecting with old colleagues and friends as I return to the UK.”

He qualified as a physician in his native South Africa and has spent over 16 years working in the pharmaceutical industry at companies such as Pfizer and Novartis. During this time he held domestic and global roles in areas such as medical affairs and business leadership.

He previously spent two years at Roche from 1998, serving as an international medical marketing manager and returned to the company in 2010 as head of global product strategy, immunology and ophthalmology at Roche's Genentech business.

Prior to taking moving to the UK Dallas' most recent role at San Francisco-based Genentech was to lead its approach to global oncology launch excellence and biosimilar readiness.

4th January 2013

From: Research, Sales, Marketing, Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics